{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:17:52Z","timestamp":1792189072828,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Schilling Stiftung im Stifterverand der Deutschen Wissenschaft"},{"name":"DFG"},{"name":"SFB 581"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.expneurol.2011.09.015","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T20:25:22Z","timestamp":1316291122000},"page":"261-269","source":"Crossref","is-referenced-by-count":25,"title":["Therapeutic effects of PEGylated insulin-like growth factor I in the pmn mouse model of motoneuron disease"],"prefix":"10.1016","volume":"232","author":[{"given":"Sibylle","family":"Jablonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sendtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.09.015_bb0005","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1523\/JNEUROSCI.17-10-03623.1997","article-title":"TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death","volume":"17","author":"Alc\u00e1ntara","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/bc050322y","article-title":"Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation","volume":"17","author":"Basu","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.200208001","article-title":"Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease","volume":"159","author":"B\u00f6mmel","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I study group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0025","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1172\/JCI6265","article-title":"Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy","volume":"104","author":"Bordet","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0083-6729(08)00612-2","article-title":"Serine kinases of insulin receptor substrate proteins","volume":"80","author":"Boura-Halfon","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/neu.10013","article-title":"The neurotrophin receptors, trkB and p75, differentially regulate motor axonal regeneration","volume":"49","author":"Boyd","year":"2001","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0045","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0701885","article-title":"The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse","volume":"124","author":"Duong","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2007.11.058","article-title":"Low intensity exercise attenuates disease progression and stimulates cell proliferation in the spinal cord of a mouse model with progressive motor neuronopathy","volume":"152","author":"Ferrer-Alcon","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0960-9822(03)00206-9","article-title":"Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease","volume":"13","author":"Ferri","year":"2003","journal-title":"Curr. Biol."},{"issue":"suppl","key":"10.1016\/j.expneurol.2011.09.015_bb0290","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0022-510X(95)00080-L","article-title":"The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies","volume":"129","author":"Festoff","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2008.12.003","article-title":"Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS","volume":"33","author":"Franz","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0075","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","article-title":"Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration","volume":"161","author":"Gregorevic","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"suppl","key":"10.1016\/j.expneurol.2011.09.015_bb0295","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0022-510X(98)00207-X","article-title":"Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action","volume":"160","author":"Haase","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"suppl.","key":"10.1016\/j.expneurol.2011.09.015_bb0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-510X(95)00081-C","article-title":"Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease","volume":"129","author":"Hanta\u00ef","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of PEGylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","article-title":"Effect of PEG conjugation on insulin properties","volume":"54","author":"Hinds","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn1624","article-title":"Molecular motors and mechanisms of directional transport in neurons","volume":"6","author":"Hirokawa","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-510X(99)00237-3","article-title":"Comparative analysis of motoneuron loss and functional deficits in PMN mice: implications for human motoneuron disease","volume":"169","author":"Holtmann","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jnr.490360607","article-title":"Members of several gene families influence survival of rat motoneurons in vitro and in vivo","volume":"36","author":"Hughes","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0022-510X(99)00238-5","article-title":"Prevention by insulin-like growth factor-I and riluzole in motor neuron death after neonatal axotomy","volume":"169","author":"Iwasaki","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0014-5793(03)00438-1","article-title":"Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signaling","volume":"546","author":"Johnston","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14728210902907847","article-title":"Emerging PEGylated drugs","volume":"14","author":"Kang","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-510X(00)00423-8","article-title":"Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn)","volume":"180","author":"Kennel","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0140","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/hmg\/ddr126","article-title":"Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A","volume":"20","author":"Kumar","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0145","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I study group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","article-title":"Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS","volume":"1185","author":"Lepore","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/hmg\/11.14.1615","article-title":"In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice","volume":"11","author":"Lesbordes","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/exnr.1993.1177","article-title":"Insulin-like growth factor-I: potential for treatment of motor neuronal disorders","volume":"124","author":"Lewis","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ng1016","article-title":"A missense mutation in Tbce causes progressive motor neuronopathy in mice","volume":"32","author":"Martin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0170","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1471-4159.1991.tb08250.x","article-title":"Recombinant human and rat ciliary neurotrophic factors","volume":"57","author":"Masiakowski","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/365027a0","article-title":"Disruption of the CNTF gene results in motor neuron degeneration","volume":"365","author":"Masu","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0180","doi-asserted-by":"crossref","first-page":"19501","DOI":"10.1074\/jbc.M110.172189","article-title":"Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I","volume":"286","author":"Metzger","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2005.04.011","article-title":"Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis","volume":"235","author":"Nagano","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0190","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1179\/016164105X39860","article-title":"Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis","volume":"27","author":"Nagano","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0195","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jnr.20668","article-title":"Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice","volume":"82","author":"Narai","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0200","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/neu.480241203","article-title":"Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival","volume":"24","author":"Neff","year":"1993","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ghir.2011.07.006","article-title":"PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders","volume":"21","author":"Saenger","year":"2011","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0215","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1523\/JNEUROSCI.18-03-01132.1998","article-title":"Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease","volume":"18","author":"Sagot","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bjp.0703633","article-title":"An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease","volume":"131","author":"Sagot","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0225","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1152\/ajpendo.00101.2006","article-title":"Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice","volume":"291","author":"Schertzer","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005072-199105000-00002","article-title":"A new mouse mutant with progressive motor neuronopathy","volume":"50","author":"Schmalbruch","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0235","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/358502a0","article-title":"Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy","volume":"358","author":"Sendtner","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.118.1.139","article-title":"Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration","volume":"118","author":"Sendtner","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0245","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1523\/JNEUROSCI.17-18-06999.1997","article-title":"Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice","volume":"17","author":"Sendtner","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1471-4159.2006.04366.x","article-title":"Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age","volume":"101","author":"Simonin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0255","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/82868","article-title":"Neurotrophins are required for nerve growth during development","volume":"4","author":"Tucker","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(00)00551-0","article-title":"Phosphatidylinositol 3-kinase activity in murine motoneuron disease: the progressive motor neuropathy mouse","volume":"103","author":"Wagey","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0275","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2010.04.021","article-title":"PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin","volume":"145","author":"Wang","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.expneurol.2011.09.015_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2009.193","article-title":"Isolation and enrichment of embryonic mouse motoneurons from the lumbar spinal cord of individual mouse embryos","volume":"5","author":"Wiese","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2011.09.015_bb0285","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0962-8924(01)02129-8","article-title":"Insulin resistance: a phosphorylation-based uncoupling of insulin signaling","volume":"11","author":"Zick","year":"2001","journal-title":"Trends Cell Biol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611003232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611003232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T16:49:38Z","timestamp":1560617378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611003232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0014488611003232"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.09.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}